315 related articles for article (PubMed ID: 38228253)
1. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ
Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.
Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk KC; Sortwell CE
J Neuroinflammation; 2024 Apr; 21(1):108. PubMed ID: 38664840
[TBL] [Abstract][Full Text] [Related]
3. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
Duffy MF; Collier TJ; Patterson JR; Kemp CJ; Luk KC; Tansey MG; Paumier KL; Kanaan NM; Fischer DL; Polinski NK; Barth OL; Howe JW; Vaikath NN; Majbour NK; El-Agnaf OMA; Sortwell CE
J Neuroinflammation; 2018 May; 15(1):129. PubMed ID: 29716614
[TBL] [Abstract][Full Text] [Related]
4. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
[TBL] [Abstract][Full Text] [Related]
5. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
[TBL] [Abstract][Full Text] [Related]
6. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
[TBL] [Abstract][Full Text] [Related]
7. Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model.
Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk K; Sortwell CE
Res Sq; 2023 May; ():. PubMed ID: 37205534
[TBL] [Abstract][Full Text] [Related]
8. Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS.
Miller KM; Patterson JR; Kochmanski J; Kemp CJ; Stoll AC; Onyekpe CU; Cole-Strauss A; Steece-Collier K; Howe JW; Luk KC; Sortwell CE
J Neurosci; 2021 Mar; 41(9):2039-2052. PubMed ID: 33472823
[TBL] [Abstract][Full Text] [Related]
9. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
[TBL] [Abstract][Full Text] [Related]
10. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
Stoll AC; Sortwell CE
Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290
[TBL] [Abstract][Full Text] [Related]
11. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
[TBL] [Abstract][Full Text] [Related]
12. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
[TBL] [Abstract][Full Text] [Related]
13. STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.
Hinkle JT; Patel J; Panicker N; Karuppagounder SS; Biswas D; Belingon B; Chen R; Brahmachari S; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118819119. PubMed ID: 35394877
[TBL] [Abstract][Full Text] [Related]
14. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002
[TBL] [Abstract][Full Text] [Related]
15. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
[TBL] [Abstract][Full Text] [Related]
18. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
[TBL] [Abstract][Full Text] [Related]
19. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
20. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
